Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Boostrix Generic Name & Formulations
Legal Class
General Description
Pharmacological Class
How Supplied
Single-dose vials or prefilled syringes (without needles)—10
Manufacturer
Boostrix Indications
Indications
Diphtheria, tetanus, and pertussis booster immunization in patients ≥10 years of age. Immunization during the 3rd trimester of pregnancy to prevent pertussis in infants <2 months of age.
Boostrix Dosage and Administration
Adults and Children
Booster immunization: <10yrs: not recommended. ≥10yrs (≥5yrs after last childhood DTwP or DTaP or adult Td vaccine): 0.5mL IM once into deltoid muscle. Immunization during 3rd trimester of pregnancy: 0.5mL IM once into deltoid muscle.
Boostrix Contraindications
Contraindications
Boostrix Boxed Warnings
Not Applicable
Boostrix Warnings/Precautions
Warnings/Precautions
Guillain-Barre syndrome (within 6 weeks) after previous tetanus toxoid vaccine: see full labeling. Progressive or unstable neurologic disorders (eg, cerebrovascular events, acute encephalopathic conditions). Previous Arthus-type hypersensitivity reaction: not recommended until ≥10yrs after prior dose of tetanus toxoid-containing vaccine. Immunosuppressed. Have epinephrine available. Latex allergy. Pregnancy: see full labeling. Nursing mothers.
Boostrix Pharmacokinetics
See Literature
Boostrix Interactions
Interactions
Concomitant vaccines: see full labeling. Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response.
Boostrix Adverse Reactions
Adverse Reactions
Local reactions (eg, pain, redness, swelling), fever, headache, fatigue, GI upset.
Boostrix Clinical Trials
See Literature
Boostrix Note
Notes
Boostrix Patient Counseling
See Literature
Images
